Covered by insurance in all 50 states, incl. Medicare Advantage day one
Siggy
Back to Blog

Hydroxyzine for Anxiety: An Antihistamine, Not a Benzodiazepine

Clinically reviewed by Daniel Montville, MD

Reviewed November 16, 2026 · Last updated November 16, 2026

Key Takeaways

  • Hydroxyzine is a first-generation antihistamine. It calms anxiety by blocking histamine H1 receptors in the brain, a different target from benzodiazepines, which boost GABA.
  • Its calming effect usually starts within 15 to 30 minutes. A single 25 mg dose occupied about 54% of brain H1 receptors in a PET study, enough to place it in the sedating range.
  • Drowsiness is the most common side effect and often fades within a few days of continued use or after a dose reduction, according to the FDA label.
  • Hydroxyzine isn't a controlled substance, but it can prolong the QT interval, a heart rhythm measure, and it's contraindicated in people who already have a prolonged QT interval and in early pregnancy.
  • Trials show hydroxyzine beats placebo for generalized anxiety disorder, yet the evidence is limited. Guidelines treat it as a second-line option, and the label says use beyond 4 months hasn't been systematically studied.

Your prescriber mentions hydroxyzine, and the first question in your head is usually some version of “Is this like Xanax?” It’s a fair question. Both can take the edge off anxiety quickly. They just get there by very different routes.

Your brain uses histamine as one of its wake-up signals, and when that signal is dialed down, you feel calmer and sleepier. Hydroxyzine blocks histamine’s H1 receptor in the brain with enough precision that imaging can measure how many receptors a single dose occupies, and a 2019 imaging review shows that occupancy tracks closely with how sedating a drug is.

For fast relief, the familiar standard has been benzodiazepines such as alprazolam (Xanax), which boost GABA, the brain’s main calming system. Alprazolam is FDA-approved for the acute treatment of generalized anxiety disorder (GAD) and for panic disorder, and the alprazolam prescribing information reports that it outperformed placebo at every evaluation point in four-week GAD trials. The results are real, and the science is well-established.

But fast relief no longer has to mean accepting a boxed warning for addiction and dependence, and at Siggy we believe you deserve to understand every non-controlled option before anyone reaches for a controlled one.

Hydroxyzine is a first-generation antihistamine that eases anxiety by blocking histamine H1 receptors in the brain rather than amplifying GABA. It targets the same moment of acute distress through a different receptor, and a 2025 Frontiers review notes that it has no significant potential for dependence or misuse and isn’t a controlled substance. That difference comes down to receptor pharmacology.

Here’s what this guide covers:

What Is Hydroxyzine Approved For?

Hydroxyzine comes as hydroxyzine hydrochloride tablets and as hydroxyzine pamoate capsules, which are sold under the brand name Vistaril. The hydroxyzine FDA label lists its uses as relief of anxiety and tension, including anxiety that shows up alongside physical illness, plus itching from allergic conditions and sedation before or after surgery.

The same label adds two details worth knowing. It describes hydroxyzine as chemically unrelated to benzodiazepines and as not acting as a cortical depressant, meaning it doesn’t broadly slow the brain’s outer layers. It also says its effectiveness for anxiety beyond 4 months hasn’t been assessed in systematic studies, so prescribers should check in periodically about whether it’s still helping.

How Does Hydroxyzine Calm Anxiety?

Histamine-releasing neurons help keep your brain awake and alert. First-generation antihistamines like hydroxyzine cross into the brain and bind the H1 receptor as inverse agonists, which turns that alerting signal down. The 2019 review explains that brain H1 receptor occupancy is the best-studied predictor of sedation, with drugs above 50% occupancy classified as sedating.

Hydroxyzine sits squarely in that range. In a 2014 PET study of 12 healthy men, a single 25 mg dose occupied about 54% of brain H1 receptors, and some participants reported sleepiness. For anxiety, the calming and the drowsiness largely come from the same action, which is why you can’t fully separate the two.

Like other first-generation antihistamines, hydroxyzine also has weaker effects beyond histamine. An Allergy journal review notes that most first-generation drugs have anticholinergic and anti-serotonin effects that can contribute to side effects. Here’s how the effects you might notice map to what’s happening underneath.

What You Notice What’s Behind It What to Know
Calm, drowsy feeling Brain H1 receptor blockade Often starts in 15 to 30 minutes
Drowsiness easing Continued use or a lower dose May fade within a few days
Dry mouth Anticholinergic activity Usually mild
Rare heart rhythm change Cardiac potassium channel blockade Risk rises with other heart risks

The timing and drowsiness details come from the FDA label, which describes side effects as usually mild and transitory. The heart rhythm row reflects a 2017 safety re-evaluation, which showed hydroxyzine blocks the hERG potassium channel in lab studies.

How Fast Does Hydroxyzine Work, and How Long Does It Last?

Hydroxyzine is absorbed quickly, and the label says its effects are usually noticeable within 15 to 30 minutes of an oral dose. That fast onset is the main reason it’s useful for anxiety that spikes in the moment.

The calming effect can also outlast the moment. The 2019 imaging review notes that sedating antihistamines can stay active in the brain longer than their blood levels suggest, which may help explain why an evening dose can leave some people groggy the next morning. If that’s happening to you, our guide to hydroxyzine side effects and next-day grogginess covers practical fixes to discuss with your prescriber.

How Is Hydroxyzine Different From Benzodiazepines and SSRIs?

Benzodiazepines bind GABA-A receptors and enhance the brain’s own calming signal. The alprazolam label carries a boxed warning for abuse, misuse, addiction, physical dependence, and withdrawal reactions, and it warns that benzodiazepines add to the effects of other central nervous system depressants, including alcohol and antihistamines. Hydroxyzine carries no such boxed warning.

On effectiveness, the picture is promising but thin. A 2010 Cochrane review of 5 randomized trials and 884 people with GAD found hydroxyzine worked better than placebo and about as well as benzodiazepines and buspirone. The reviewers also found a high risk of bias in those trials and concluded hydroxyzine can’t be recommended as a reliable first-line GAD treatment. In a 3-month randomized trial of 334 outpatients, hydroxyzine 50 mg a day improved anxiety scores more than placebo and performed similarly to the benzodiazepine bromazepam, with less drowsiness than bromazepam.

The Frontiers review offers a fair counterweight: some evidence suggests hydroxyzine is less effective than alprazolam for acute anxiety at comparable doses, and its research base is limited.

SSRIs work on a different timescale and goal. Canadian anxiety guidelines list several SSRIs as first-line GAD treatments and cite relapse-prevention studies in which continuing an SSRI sharply cut relapse rates compared with placebo. The same guidelines place hydroxyzine among second-line options, noting that clinical experience with it for GAD remains limited.

What Are the Side Effects and Safety Limits?

Most side effects are mild. The label lists drowsiness and dry mouth as the most familiar, along with headache and, rarely, tremor or convulsions, usually at doses well above those recommended. Side effects are worth reporting early, so you aren’t left feeling like “when side effects start, you’re on your own until the next appointment.”

Heart rhythm is the safety issue to take seriously. Hydroxyzine can prolong the QT interval, a measure of how the heart recharges between beats, and the label lists QT prolongation and torsade de pointes, a dangerous rhythm, among reported reactions. The 2017 re-evaluation reviewed 59 reports of QT prolongation or torsade de pointes collected between 1955 and 2016. Apart from intentional overdose, every case involved at least one other risk factor, most often heart disease combined with another medication known to affect heart rhythm.

According to the label, hydroxyzine shouldn’t be used if you:

  • Already have a prolonged QT interval
  • Are in early pregnancy
  • Are breastfeeding
  • Are allergic to hydroxyzine, cetirizine, or levocetirizine

The label also advises starting older adults at low doses, since sedating drugs can cause confusion and oversedation in that age group, and it notes hydroxyzine can strengthen the effects of some other sedating drugs, such as meperidine and barbiturates. If you drink, our guide to hydroxyzine and alcohol explains why the combination deserves caution. If you faint, feel your heart racing irregularly, or have a seizure, call 911.

Where Does Hydroxyzine Fit in an Anxiety Plan?

Hydroxyzine’s profile makes it a reasonable candidate for short-term relief: anxiety that flares in specific situations, anxiety that disrupts sleep, or the early weeks while a longer-term treatment starts to work. Because the label hasn’t established its effectiveness beyond 4 months, ongoing daily anxiety usually calls for a conversation about first-line options.

Those options include psychotherapy as well as medication. The Canadian guidelines describe cognitive behavioral therapy (CBT) as an effective first-line GAD treatment that’s as effective as medication. For a closer look at trial results and dosing, see our guide on how well hydroxyzine works and who it fits.

Start Your Anonymous Intake

Hydroxyzine is a fast, non-controlled antihistamine with real but limited evidence for anxiety. Its trade-offs are drowsiness, a heart rhythm risk that matters most if you already have risk factors, and a label that hasn’t established long-term use. It tends to work best as one piece of a plan that also addresses the anxiety underneath, which is why our guide to hydroxyzine vs. Buspar is worth reading if you’re weighing options.

Siggy doesn’t prescribe controlled substances, and you can start free and anonymously, with no account, no card, and no name required. You share what you’re dealing with and get a summary of your history that you can download and share with any clinician. A licensed clinician reviews your intake before any prescription is written.

Start your anonymous intake and talk through which anxiety options fit your life.

This article is for education and isn’t a substitute for advice from your own clinician.

Mental healthcare should stay with you between appointments.

Siggy combines daily check-ins with clinician-supervised care so your treatment plan can respond to what is actually happening.

Start anonymously. A real doctor reviews every clinical decision. HIPAA-compliant.

Start Anonymous Intake

Frequently Asked Questions

How does hydroxyzine work for anxiety?

Hydroxyzine works by blocking histamine H1 receptors in the brain. Histamine helps keep you alert, so blocking it lowers arousal and produces a calm, often drowsy feeling. Unlike benzodiazepines, it doesn't act on GABA receptors, and the FDA label notes it's chemically unrelated to benzodiazepines.

How long does it take hydroxyzine to work for anxiety?

Hydroxyzine usually starts working within 15 to 30 minutes of an oral dose, according to its FDA label. That quick onset is why it's often used for short-term or situational anxiety rather than as a daily, long-term anxiety treatment.

Is hydroxyzine a benzodiazepine?

No. Hydroxyzine is a first-generation antihistamine, and its label states it's chemically unrelated to benzodiazepines. It isn't a controlled substance and doesn't carry the boxed warning for addiction, dependence, and withdrawal that benzodiazepines such as alprazolam carry.

Is hydroxyzine as effective as Xanax for anxiety?

For generalized anxiety disorder, a Cochrane review of 5 trials found hydroxyzine performed about as well as benzodiazepines and buspirone, but the trials had a high risk of bias. A 2025 review noted some evidence that hydroxyzine is less effective than alprazolam (Xanax) for acute anxiety at comparable doses. Your prescriber can weigh effectiveness against dependence risk for your situation.

Does the drowsiness from hydroxyzine go away?

Often, yes. The FDA label says drowsiness is usually temporary and may disappear within a few days of continued use or after lowering the dose. If drowsiness affects your work or driving, tell your prescriber, since timing and dose can be adjusted.

Who should not take hydroxyzine?

Hydroxyzine's label says not to use it if you have a prolonged QT interval, are in early pregnancy, are breastfeeding, or are allergic to hydroxyzine, cetirizine, or levocetirizine. Older adults usually start at low doses because sedating drugs can cause confusion. Share your full medication list, since other drugs can raise heart rhythm risk.

Sources

  1. Kawauchi H, Yanai K, Wang DY, et al. Antihistamines for Allergic Rhinitis Treatment from the Viewpoint of Nonsedative Properties. International Journal of Molecular Sciences. 2019;20(1):213.
  2. U.S. National Library of Medicine, DailyMed. Alprazolam Tablets Prescribing Information. Label revised January 2026.
  3. Krieger A. Benzos (As) Needed: Research Into As-Needed and Intermittent Benzodiazepines for Anxiety Is Required for Comprehensive Best Prescribing Practices. Frontiers in Psychiatry. 2025;16.
  4. U.S. National Library of Medicine, DailyMed. Hydroxyzine Hydrochloride Tablets Prescribing Information. Label revised July 2025.
  5. Farré M, Pérez-Mañá C, Papaseit E, et al. Bilastine vs. Hydroxyzine: Occupation of Brain Histamine H1-Receptors Evaluated by Positron Emission Tomography in Healthy Volunteers. British Journal of Clinical Pharmacology. 2014;78(5):970-980.
  6. Baroody FM, Naclerio RM. Antiallergic Effects of H1-Receptor Antagonists. Allergy. 2000;55(s64):17-27.
  7. Schlit AF, Delaunois A, Colomar A, et al. Risk of QT Prolongation and Torsade de Pointes Associated With Exposure to Hydroxyzine: Re-evaluation of an Established Drug. Pharmacology Research and Perspectives. 2017;5(3):e00309.
  8. Guaiana G, Barbui C, Cipriani A. Hydroxyzine for Generalised Anxiety Disorder. Cochrane Database of Systematic Reviews. 2010;(12):CD006815.
  9. Llorca PM, Spadone C, Sol O, et al. Efficacy and Safety of Hydroxyzine in the Treatment of Generalized Anxiety Disorder: A 3-Month Double-Blind Study. Journal of Clinical Psychiatry. 2002;63(11):1020-1027.
  10. Katzman MA, Bleau P, Blier P, et al. Canadian Clinical Practice Guidelines for the Management of Anxiety, Posttraumatic Stress and Obsessive-Compulsive Disorders. BMC Psychiatry. 2014;14(Suppl 1):S1.